Product image of Innovair Nexthaler (Beclometasone Dipropionate, Formoterol Fumarate Dihydrate) supplied by GNH India

Innovair Nexthaler

Active Ingredient:
Beclometasone Dipropionate, Formoterol Fumarate Dihydrate
Origin:
EU

Innovair Nexthaler (Beclometasone Dipropionate, Formoterol Fumarate Dihydrate)

Beclometasone dipropionate / formoterol fumarate, the active ingredient in Innovair Nexthaler, is an inhaled corticosteroid/long‑acting beta2‑agonist combination presented as a dry‑powder inhaler for inhalation use. It provides maintenance therapy for asthma and chronic obstructive pulmonary disease (COPD) in adult patients. It is indicated for regular use to improve lung function and reduce exacerbations.

GNH India supplies Innovair Nexthaler as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory documentation for each shipment.

Manufacturer / TM Owner

Chiesi S.A.S.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Innovair Nexthaler combines an inhaled corticosteroid with a long‑acting β2‑agonist to treat airway diseases.

  • Asthma: improves symptom control and reduces the risk of severe attacks.
  • Chronic obstructive pulmonary disease (COPD): helps maintain airflow and decreases symptom frequency.
  • Maintenance therapy: reduces the frequency of exacerbations in chronic respiratory conditions.

How It Works

  • Beclometasone dipropionate binds to glucocorticoid receptors in airway cells, suppressing inflammatory gene expression and cytokine release. Formoterol fumarate selectively stimulates β2‑adrenergic receptors on bronchial smooth muscle, increasing cyclic AMP levels and causing sustained bronchodilation. The combined actions reduce airway inflammation while keeping the airways open for easier breathing.

Side Effects

Common Side Effects

  • Throat irritation or soreness.
  • Oral candidiasis (thrush).
  • Hoarseness of voice.

Serious or Rare Side Effects

  • Paradoxical bronchospasm.
  • Adrenal suppression with prolonged high‑dose use.
  • Severe allergic reaction, including anaphylaxis.

Precautions & Warnings

Before initiating therapy, consider the following precautions:

  • Assess for active respiratory infections: treat infection before use.
  • Monitor for oral candidiasis: advise rinsing mouth after inhalation.
  • Evaluate cardiac history: caution in patients with arrhythmias.
  • Use the lowest effective dose to achieve control.
  • Educate on proper inhaler technique to minimize local irritation.
  • Store at ambient temperature: keep in original container, protect from moisture and heat.

Avoid Interactions

Major Interactions (Avoid)

  • Non‑selective β‑blockers: may blunt bronchodilator effect.
  • Strong CYP3A4 inhibitors (e.g., ketoconazole): increase corticosteroid exposure.
  • Diuretics: may enhance hypokalemia risk.

Moderate Interactions (Monitor Closely)

  • Theophylline: may increase risk of tachycardia.
  • Ritonavir and other protease inhibitors: may raise systemic steroid levels.
  • Anticholinergic bronchodilators: monitor for additive bronchial effects.

Frequently Asked Questions

Innovair Nexthaler is prescribed as a maintenance inhaler for adults with asthma or chronic obstructive pulmonary disease (COPD). It helps control symptoms, improve lung function, and lower the frequency of disease‑related exacerbations when used regularly as part of a long‑term treatment plan.

Beclometasone dipropionate reduces airway inflammation by activating glucocorticoid receptors and suppressing inflammatory mediators. Formoterol fumarate stimulates β2‑adrenergic receptors on bronchial smooth muscle, increasing cyclic AMP and causing prolonged bronchodilation. Together they provide anti‑inflammatory and bronchodilatory effects.

The prescribed dose is determined by the treating clinician based on disease severity and individual response. In many regions the typical regimen involves one inhalation twice daily, but exact dosing and frequency must follow the prescriber’s instructions and the product label.

Safety data for use in pregnancy and lactation are limited. The medication should only be used if the potential benefit justifies any potential risk to the fetus or infant. Patients who are pregnant, planning pregnancy, or breastfeeding should discuss treatment options with their healthcare provider.

To place an order, submit an enquiry on the Innovair Nexthaler product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Innovair Nexthaler delivers the same therapeutic class as other ICS/LABA products such as budesonide/formoterol (Symbicort) or fluticasone/salmeterol (Advair). Differences lie mainly in the device technology, particle size distribution, and specific dosing recommendations. Clinical efficacy is comparable when used according to label, while patient preference may guide device selection.

Store the inhaler at ambient temperature, below 25 °C, in its original packaging. Protect it from excessive moisture, direct sunlight, and extreme heat. Keep the device out of reach of children and do not expose it to freezing conditions.

The device is a dry‑powder inhaler. The patient should exhale fully away from the mouthpiece, place the inhaler in the mouth, seal lips around the opening, and inhale sharply and deeply. After inhalation, hold the breath for about 10 seconds, then breathe out slowly. Rinse the mouth with water to reduce local side effects.

Serious risks include paradoxical bronchospasm, which can worsen breathing, adrenal suppression with prolonged high‑dose use, and severe allergic reactions such as anaphylaxis. Patients should seek immediate medical attention if they experience sudden worsening of breathlessness, swelling, rash, or signs of an allergic response.

Innovair Nexthaler is contraindicated in patients with a known hypersensitivity to beclometasone dipropionate, formoterol fumarate, or any excipients in the inhaler. It should also be avoided in individuals who have experienced a severe paradoxical bronchospasm after using a similar medication.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Beclometasone Dipropionate, Formoterol Fumarate Dihydrate

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT